FDA Inspection
Evaric Pharmaceuticals Inc.Evaric Pharmaceuticals Inc. – FDA Inspection, May 29, 2019
Record Details
This FDA Inspection record concerns Evaric Pharmaceuticals Inc., with an inspection on May 29, 2019, issued by the New York District Office, covering human drugs.
- Office
- New York District Office
- Person
- Jay T. Wong (Issuing Officer)
View Company Profile
ID · 068acee6-2c64-4678-8352-8af0ecd7e53c
Inspection Facts
- Inspection number
- 1091300
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Evaric Pharmaceuticals Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| May 16, 2025 | VAI | New York District Office | Drug Quality Assurance |
| February 7, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Evaric Pharmaceuticals Inc.
- FDA Inspection 1270045 - 2025-05-16
- FDA Inspection 999784 - 2017-02-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.